Skip to content
2000
Volume 13, Issue 8
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666

Abstract

Tumor suppressor p53 maintains genome stability by regulating diverse cellular functions including cell cycle arrest, apoptosis, senescence and metabolic homeostasis. Mutations in the p53 gene occur in almost all human cancers with a frequency of up to 80%. However, it is only 20% in breast cancers, 18% in endometrial cancers and 1.5% in cervical cancers. Estrogen receptor alpha (ERα) plays a pivotal role in hormone-dependent cancer development and the status of ERα is used for designing treatment strategy and for prognosis. A closer look at the cross-talk between p53 and ERα has revealed that their activities are mutually regulated. This review will summarize the current body of knowledge on p53, ERα and ERβ in cancer. Clinical correlations between estrogen receptors and p53 status have also been reported. Thus, this review will discuss the relationship between p53 and ERs at both the molecular and clinical levels.

Loading

Article metrics loading...

/content/journals/cmm/10.2174/15665240113139990065
2013-09-01
2025-08-17
Loading full text...

Full text loading...

/content/journals/cmm/10.2174/15665240113139990065
Loading

  • Article Type:
    Research Article
Keyword(s): Estrogen receptor; hormone-dependent cancer; p53; transcription factors
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test